Stifel analyst Mark Astrachan raised the firm’s price target on Procter & Gamble to $161 from $155 and keeps a Hold rating on the shares. The firm lifted its FY24-FY25 EPS estimates slightly following “solid” fiscal Q4 results with organic sales above consensus, in part reflecting lessening volume declines and EBIT upside that was driven by meaningful gross margin expansion, but it views P&G shares as trading near fair value at current levels.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PG:
- Procter & Gamble price target raised to $173 from $170 at Deutsche Bank
- Procter & Gamble price target raised to $172 from $164 at JPMorgan
- Procter & Gamble (NYSE:PG) Ticks Higher on Strong Sales, Margin Expansion
- Procter & Gamble: Promotional environment ‘stable,’ no interest in changing it
- Procter & Gamble says ‘still navigating through plenty of challenges’